STVNStevanato Group S.p.A.

$19.38-27% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: earnings up +19% year on year, but operating margin narrowing (−2.5 points).

1 good, 1 to watch, 1 neutral
Revenue trend+7% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.

Earnings trend+19% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−2.5 points operating

Trailing-twelve-month operating margin, 16.8% now against 19.2% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is STVN growing?

Stevanato Group S.p.A. has grown revenue 6.4% a year over three years and 12% a year over five, with earnings per share compounding at −1.9%.

+6.4%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate
+12%

Revenue growth, 5-year rate · +6.4% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−1.9%

Earnings per share, 3-year rate · revenue +6.4% · earnings lagged revenue: the growth is costing something

Years of annual history on file
7

Years of annual history on file · FY2019 to FY2025, as filed

Details›
Revenue FY2021
$844M
Revenue FY2022
$984M
Revenue FY2023
$1.09B
Revenue FY2024
$1.10B
Revenue FY2025
$1.19B

Annual income statements as filed with the SEC.